Lamivir S Tablet (Lamivudine + Stavudine): Antiretroviral Tablet | For HIV Infection Management
Lamivir S Tablet contains lamivudine 150 mg and stavudine, commonly available in strengths of 30 mg or 40 mg. This antiviral combination is used to manage HIV-1 infection by helping limit viral multiplication as part of an appropriate combination treatment plan. Confirm the exact strength on the product packaging.
Product Overview
Lamivir S Tablet is a combination of two antiviral medicines, lamivudine and stavudine, used as part of treatment for HIV-1 infection. These ingredients work by interfering with the virus’s ability to make copies of itself, helping control viral activity when used as part of an appropriate treatment plan.
How Lamivir S Tablet Works
HIV uses an enzyme called reverse transcriptase to convert its genetic material into a form that allows it to reproduce inside human cells. Lamivudine and stavudine interfere with this process by acting as nucleoside analogues.
When these ingredients are incorporated into the developing viral genetic material, they interrupt further formation of the chain. This limits the virus’s ability to make additional copies of itself.
The combination targets viral replication through two medicines in the same general drug class. However, it is important to understand that Lamivir S Tablet is not a complete treatment on its own. Its suitability depends on the overall treatment plan, the virus’s response to medicines, and current clinical recommendations.
Role in HIV-1 Infection Management
Lamivir S Tablet has been used as part of antiretroviral treatment for HIV-1 infection. The purpose of antiviral treatment is to reduce viral activity and support the long-term management of the infection.
An appropriate treatment plan aims to maintain viral suppression, preserve immune system function, and reduce the risk of complications associated with uncontrolled HIV. The combination and duration of treatment depend on individual clinical factors and current treatment guidance.
Because stavudine is associated with important safety concerns and is no longer preferred in many modern treatment guidelines, its suitability should be reviewed by a qualified healthcare professional. Do not start this combination or change an existing treatment plan based solely on general product information.
Importance of Consistent Treatment
Antiviral treatment works best when taken according to a consistent schedule. Taking medicines irregularly can affect viral control and may contribute to treatment failure or the development of resistance.
A regular daily routine can help reduce missed doses. If difficulties with the treatment schedule arise, discuss them with a healthcare professional rather than stopping treatment independently. Any change to the combination should be planned carefully to maintain appropriate infection management.
Storage Information
Store Lamivir S Tablet according to the instructions printed on its packaging. Keep the tablets away from excess heat and moisture, and store them in a secure place out of children’s reach. Do not use tablets if their packaging is damaged or the product has passed its stated expiry date.
Summary
Lamivir S Tablet combines lamivudine and stavudine, two antiviral medicines that interfere with HIV replication. It has been used as part of combination treatment for HIV-1 infection, helping control viral activity when included in an appropriate treatment plan.
The exact formulation should be confirmed from the packaging, and the continued suitability of stavudine should be reviewed with a healthcare professional because of its recognised safety concerns and the availability of newer treatment options. Consistent use according to professional guidance is essential for effective treatment management.
Precaution
1. Follow the Recommended Dose
Take Lamivir S Tablet only according to your healthcare professional’s instructions. Do not change the dose without guidance.
2. Confirm the Product Strength
Lamivir S may be available in different strengths. Check the packaging to confirm the amounts of lamivudine and stavudine before use.
3. Monitor Nerve Health
Stavudine may cause nerve-related problems, such as tingling, numbness, or burning sensations in the hands and feet. Report these symptoms promptly.
4. Discuss Liver and Kidney Conditions
Inform your healthcare professional about any liver or kidney problems, as these may affect medicine selection and dosing.
5. Review Other Medicines
Share details of all medicines, vitamins, and supplements you take to help identify possible interactions or overlapping ingredients.
6. Maintain Regular Follow-Ups
Attend recommended check-ups and laboratory tests to monitor treatment response and identify potential complications early.
7. Do Not Stop Treatment Independently
Do not stop or change Lamivir S Tablet without medical guidance. Treatment changes should be planned to maintain appropriate infection control.
Usage
Lamivir S Tablet contains lamivudine and stavudine, antiviral medicines that have been used as part of combination treatment for HIV-1 infection. The exact formulation and strength should be confirmed from the product packaging before use.
How to Take Lamivir S Tablet
Take Lamivir S Tablet only according to your healthcare professional’s instructions. Follow the guidance for your specific formulation and do not adjust the dose independently.
Maintain a Consistent Schedule
Follow the recommended dosing schedule to help maintain consistent medicine levels. If you have difficulty following the routine, seek professional guidance.
What to Do If You Miss a Dose
Follow the missed-dose instructions supplied with your medicine or contact your healthcare professional. Do not take an extra dose to make up for a missed one.
Uses
Lamivir S Tablet contains lamivudine and stavudine, two antiviral medicines that have been used in combination treatment for HIV-1 infection. They work by interfering with viral replication and helping control viral activity.
1. HIV-1 Infection Management
Lamivir S Tablet has been used as part of combination treatment to help manage HIV-1 infection and reduce viral multiplication.
2. Helps Limit Viral Replication
Lamivudine and stavudine interfere with reverse transcriptase, an enzyme HIV needs to reproduce. This helps limit the formation of new virus particles.
3. Supports Viral Control
When included in an appropriate treatment plan, these medicines can help control viral activity and support long-term infection management.
4. Supports Immune System Management
Controlling viral activity is an important part of maintaining immune system function during HIV treatment.
Important: Lamivir S contains stavudine, which can cause serious side effects and is not preferred in many current treatment guidelines. A qualified healthcare professional should confirm whether this combination is appropriate before use.
Side Effects
Lamivir S Tablet contains lamivudine and stavudine. Some people may experience side effects while taking this combination. The effects can vary depending on individual health, dosage, and other medicines being used.
Some possible side effects include:
Nausea: A feeling of discomfort in the stomach.
Headache: Mild or occasional head pain.
Diarrhea: Loose or frequent bowel movements.
Fatigue: Feeling unusually tired or low on energy.
Digestive Discomfort: Mild stomach pain or reduced appetite.
Contact a healthcare professional if these symptoms persist or become troublesome.
Important: Stavudine has significant safety concerns and is not preferred in many current HIV treatment guidelines. Consult a qualified healthcare professional to confirm whether Lamivir S remains suitable for your treatment plan.
FAQs
1. What is Lamivir S Tablet used for?
Lamivir S Tablet has been used as part of combination treatment for HIV-1 infection to help control viral multiplication.
2. What are the active ingredients in Lamivir S Tablet?
It contains lamivudine and stavudine. Commonly listed formulations pair lamivudine 150 mg with stavudine 30 mg or 40 mg. Check the packaging to confirm the exact strength.
3. How does Lamivir S Tablet work?
Both ingredients interfere with reverse transcriptase, an enzyme HIV needs to reproduce, helping limit viral multiplication.
4. How should Lamivir S Tablet be taken?
Follow the instructions provided by your healthcare professional for the specific product and treatment plan.
5. Can Lamivir S Tablet be taken with other medicines?
Some medicines, including didanosine and zidovudine, may cause important interactions. Share your complete medicine list with your healthcare professional.
6. What are the possible side effects of Lamivir S Tablet?
Possible effects include nausea, headache, and digestive discomfort. Stavudine can also cause serious nerve, liver, and pancreatic problems.
7. Can Lamivir S Tablet affect nerve health?
Yes. Stavudine may cause tingling, numbness, burning, or pain in the hands and feet. Report these symptoms promptly.
8. Can Lamivir S Tablet be stopped suddenly?
Do not stop or change treatment without professional guidance, as treatment changes need careful planning.
Interactions
Lamivir S Tablet contains lamivudine and stavudine. Certain medicines may affect treatment safety or increase the risk of side effects. Inform your healthcare professional about all medicines and supplements you take.
1. Other Antiviral Medicines
Some antiviral medicines may contain overlapping ingredients or require careful combination planning. Check all HIV medicines before starting or changing treatment.
2. Didanosine
Using stavudine with didanosine may increase the risk of serious side effects, including inflammation of the pancreas and nerve problems. This combination generally requires avoidance or specialist review.
3. Zidovudine
Zidovudine may interfere with the antiviral activity of stavudine. These medicines are generally not recommended for use together.
4. Medicines That May Affect the Pancreas
Some medicines can increase the risk of pancreatic inflammation when combined with stavudine. Tell your healthcare professional about any medicines associated with this complication.
5. Medicines That May Affect the Liver
Certain medicines can increase concerns about liver-related complications. Share details of your current treatments, especially if you have an existing liver condition.
6. Herbal Products and Supplements
Inform your healthcare professional about vitamins, herbal products, and supplements you use regularly so potential concerns can be reviewed.
7. Medicines for Long-Term Conditions
Medicines used for ongoing health conditions may need to be reviewed to ensure the overall treatment plan remains appropriate.
Important: Lamivir S contains stavudine, which has significant safety concerns and is not preferred in many current HIV treatment guidelines. Do not start, stop, or combine medicines without professional guidance.
| Manufacturer | : | Cipla Pharma, India |
| Equivalent Brand | : | Epivir + Zerit combination |
| Generic Search | : | Lamivudine + Stavudine |
Latest Products
